1100 13th Street, NW, Suite 1000Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2020The Kiplinger Washington Editors
Check out our weekly earnings calendar and read the latest quarterly earnings previews.
Most people may not know it, but only a handful out of every thousand drugs that begin development ever make it to the final stages of trials – and not all of those are approved.
Near term, a bias to U.S. stocks makes sense. But long term, you need to capitalize on recoveries in the rest of the world as well.
More Investing News »